Concepedia

Ramy Mahmoud

RM

53

Publications

4.1K

Citations

35

H-Index

1998

Active since

Affiliations

OptiNose (United States)(Current)

Janssen (United States)

OptiNose (Norway)

Janssen Scientific Affairs (United States)

Johnson & Johnson (United States)

Ramy Mahmoud is an author at OptiNose (United States) specializing in medicine, psychiatry, and social sciences.

ORCID

Top concepts

Publications per year

1998–2024

53

Publications

53

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Marci L. Chew, Benoit H. Mulsant, Bruce G. Pollock et al. · Journal of the American Geriatrics Society · 2008 · 486 citations

, , +14

A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder

Robert R. Conley, Ramy Mahmoud · American Journal of Psychiatry · 2001 · 333 citations

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes

Frank D. Gianfrancesco, Amy Grogg, Ramy Mahmoud et al. · The Journal of Clinical Psychiatry · 2002 · 237 citations

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

Richard Payne, Susan D. Mathias, David J. Pasta et al. · Journal of Clinical Oncology · 1998 · 227 citations

Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder

Jaspreet S. Brar, Rohan Ganguli, Gahan Pandina et al. · The Journal of Clinical Psychiatry · 2005 · 177 citations

Rows per page

1–5 of 53